APA

Tibaldi C., Ricci S., Russo F., Bernardini I., Galli L., Chioni A., Orlandini C., Grosso A. M., Pegna A. L., Fabbri A., Innocenti F., Ferrari K., Tognarini L., Conte P. F. & Falcone A. (20050712). Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO). : Lung cancer (Amsterdam, Netherlands).

Chicago

Tibaldi C, Ricci S, Russo F, Bernardini I, Galli L, Chioni A, Orlandini C, Grosso A M, Pegna A Lopes, Fabbri A, Innocenti F, Ferrari K, Tognarini L, Conte P F and Falcone A. 20050712. Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO). : Lung cancer (Amsterdam, Netherlands).

Harvard

Tibaldi C., Ricci S., Russo F., Bernardini I., Galli L., Chioni A., Orlandini C., Grosso A. M., Pegna A. L., Fabbri A., Innocenti F., Ferrari K., Tognarini L., Conte P. F. and Falcone A. (20050712). Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO). : Lung cancer (Amsterdam, Netherlands).

MLA

Tibaldi C, Ricci S, Russo F, Bernardini I, Galli L, Chioni A, Orlandini C, Grosso A M, Pegna A Lopes, Fabbri A, Innocenti F, Ferrari K, Tognarini L, Conte P F and Falcone A. Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO). : Lung cancer (Amsterdam, Netherlands). 20050712.